DRW Securities LLC Decreases Stake in HCA Healthcare, Inc. (NYSE:HCA)

DRW Securities LLC trimmed its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,420 shares of the company’s stock after selling 153 shares during the period. DRW Securities LLC’s holdings in HCA Healthcare were worth $577,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of HCA. Bangor Savings Bank lifted its holdings in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare during the second quarter worth approximately $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC boosted its holdings in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare during the second quarter worth about $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, SVP Phillip G. Billington sold 3,897 shares of the company’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 15,155 shares of company stock worth $5,608,990. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of a number of research reports. Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Truist Financial raised their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, UBS Group boosted their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $380.29.

HCA Healthcare Stock Up 1.0 %

Shares of HCA Healthcare stock opened at $328.95 on Wednesday. The stock has a market capitalization of $83.32 billion, a price-to-earnings ratio of 14.77, a PEG ratio of 1.25 and a beta of 1.68. The business’s 50 day simple moving average is $376.47 and its 200-day simple moving average is $358.74. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.80%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.